These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. GMPPA defects cause a neuromuscular disorder with α-dystroglycan hyperglycosylation. Franzka P; Henze H; Jung MJ; Schüler SC; Mittag S; Biskup K; Liebmann L; Kentache T; Morales J; Martínez B; Katona I; Herrmann T; Huebner AK; Hennings JC; Groth S; Gresing L; Horstkorte R; Marquardt T; Weis J; Kaether C; Mutchinick OM; Ori A; Huber O; Blanchard V; von Maltzahn J; Hübner CA J Clin Invest; 2021 May; 131(9):. PubMed ID: 33755596 [TBL] [Abstract][Full Text] [Related]
8. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328 [TBL] [Abstract][Full Text] [Related]
9. Lysosomal degradation of GMPPB is associated with limb-girdle muscular dystrophy type 2T. Tian WT; Zhou HY; Zhan FX; Zhu ZY; Yang J; Chen SD; Luan XH; Cao L Ann Clin Transl Neurol; 2019 Jun; 6(6):1062-1071. PubMed ID: 31211170 [TBL] [Abstract][Full Text] [Related]
10. Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan. Stevens E; Carss KJ; Cirak S; Foley AR; Torelli S; Willer T; Tambunan DE; Yau S; Brodd L; Sewry CA; Feng L; Haliloglu G; Orhan D; Dobyns WB; Enns GM; Manning M; Krause A; Salih MA; Walsh CA; Hurles M; Campbell KP; Manzini MC; ; Stemple D; Lin YY; Muntoni F Am J Hum Genet; 2013 Mar; 92(3):354-65. PubMed ID: 23453667 [TBL] [Abstract][Full Text] [Related]
11. ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases. Magri F; Colombo I; Del Bo R; Previtali S; Brusa R; Ciscato P; Scarlato M; Ronchi D; D'Angelo MG; Corti S; Moggio M; Bresolin N; Comi GP BMC Neurol; 2015 Sep; 15():172. PubMed ID: 26404900 [TBL] [Abstract][Full Text] [Related]
12. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation. Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756 [TBL] [Abstract][Full Text] [Related]
13. Mutations in GMPPA cause a glycosylation disorder characterized by intellectual disability and autonomic dysfunction. Koehler K; Malik M; Mahmood S; Gießelmann S; Beetz C; Hennings JC; Huebner AK; Grahn A; Reunert J; Nürnberg G; Thiele H; Altmüller J; Nürnberg P; Mumtaz R; Babovic-Vuksanovic D; Basel-Vanagaite L; Borck G; Brämswig J; Mühlenberg R; Sarda P; Sikiric A; Anyane-Yeboa K; Zeharia A; Ahmad A; Coubes C; Wada Y; Marquardt T; Vanderschaeghe D; Van Schaftingen E; Kurth I; Huebner A; Hübner CA Am J Hum Genet; 2013 Oct; 93(4):727-34. PubMed ID: 24035193 [TBL] [Abstract][Full Text] [Related]
14. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy. Van den Bergh PYK; Sznajer Y; Van Parys V; van Tol W; Wevers RA; Lefeber DJ; Xu L; Lek M; MacArthur DG; Johnson K; Phillips L; Töpf A; Straub V Neuromuscul Disord; 2017 Nov; 27(11):1043-1046. PubMed ID: 28803818 [TBL] [Abstract][Full Text] [Related]
15. POGLUT1 biallelic mutations cause myopathy with reduced satellite cells, α-dystroglycan hypoglycosylation and a distinctive radiological pattern. Servián-Morilla E; Cabrera-Serrano M; Johnson K; Pandey A; Ito A; Rivas E; Chamova T; Muelas N; Mongini T; Nafissi S; Claeys KG; Grewal RP; Takeuchi M; Hao H; Bönnemann C; Lopes Abath Neto O; Medne L; Brandsema J; Töpf A; Taneva A; Vilchez JJ; Tournev I; Haltiwanger RS; Takeuchi H; Jafar-Nejad H; Straub V; Paradas C Acta Neuropathol; 2020 Mar; 139(3):565-582. PubMed ID: 31897643 [TBL] [Abstract][Full Text] [Related]
16. Dolichol-phosphate mannose synthase depletion in zebrafish leads to dystrophic muscle with hypoglycosylated α-dystroglycan. Marchese M; Pappalardo A; Baldacci J; Verri T; Doccini S; Cassandrini D; Bruno C; Fiorillo C; Garcia-Gil M; Bertini E; Pitto L; Santorelli FM Biochem Biophys Res Commun; 2016 Aug; 477(1):137-143. PubMed ID: 27291147 [TBL] [Abstract][Full Text] [Related]
17. Expanding the phenotype of GMPPB mutations. Cabrera-Serrano M; Ghaoui R; Ravenscroft G; Johnsen RD; Davis MR; Corbett A; Reddel S; Sue CM; Liang C; Waddell LB; Kaur S; Lek M; North KN; MacArthur DG; Lamont PJ; Clarke NF; Laing NG Brain; 2015 Apr; 138(Pt 4):836-44. PubMed ID: 25681410 [TBL] [Abstract][Full Text] [Related]
18. Novel mutations in the C-terminal region of GMPPB causing limb-girdle muscular dystrophy overlapping with congenital myasthenic syndrome. Luo S; Cai S; Maxwell S; Yue D; Zhu W; Qiao K; Zhu Z; Zhou L; Xi J; Lu J; Beeson D; Zhao C Neuromuscul Disord; 2017 Jun; 27(6):557-564. PubMed ID: 28433477 [TBL] [Abstract][Full Text] [Related]
19. Further evidence of Fukutin mutations as a cause of childhood onset limb-girdle muscular dystrophy without mental retardation. Puckett RL; Moore SA; Winder TL; Willer T; Romansky SG; Covault KK; Campbell KP; Abdenur JE Neuromuscul Disord; 2009 May; 19(5):352-6. PubMed ID: 19342235 [TBL] [Abstract][Full Text] [Related]
20. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan. Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]